Basic Information
| RNALocate ID: | RLID:11000974 |
| RNA Symbol: | hsa-miR-96-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-96 |
| RNA ID: | miRBase:MIMAT0000095 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 19002258 |
| Tissue/Cell Line: | Peripheral blood mononuclear cells |
| Method: | qPCR |
| Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001419 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001420 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001421 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000975 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11000976 | Exosome | Brain tissue | 23382797 |
| RLID:11000977 | Exosome | Plasma | 23663360 |
| RLID-D:11000029 | Exosome | Seminal fluid|Tongue tissue | |
| RLID-D:11000294 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-96-5p | Idiopathic pulmonary fibrosis | MNDR-E-MI-72637 |
| MNDR | hsa-miR-96-5p | Splenic marginal zone lymphoma | MNDR-E-MI-72638 |
| MNDR | hsa-miR-96-5p | Pheochromocytoma | MNDR-E-MI-72639 |
| MNDR | hsa-miR-96-5p | Tongue squamous cell carcinoma | MNDR-E-MI-72640 |
| MNDR | hsa-miR-96-5p | Oral squamous cell carcinoma | MNDR-E-MI-72641 |
| MNDR | hsa-miR-96-5p | Large cell neuroendocrine cancer | MNDR-E-MI-72642 |
| MNDR | hsa-miR-96-5p | Follicular cleaved lymphoma | MNDR-E-MI-72643 |
| MNDR | hsa-miR-96-5p | Medulloblastoma | MNDR-E-MI-72644 |
| MNDR | hsa-miR-96-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-72645 |
| MNDR | hsa-miR-96-5p | Lymphoma | MNDR-E-MI-72646 |
| MNDR | hsa-miR-96-5p | Lymphoma non-hodgkin | MNDR-E-MI-72647 |
| MNDR | hsa-miR-96-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-72648 |
| MNDR | hsa-miR-96-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-72649 |
| MNDR | hsa-miR-96-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-72650 |
| MNDR | hsa-miR-96-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-72651 |
| MNDR | hsa-miR-96-5p | Her2-receptor positive breast cancer | MNDR-E-MI-72652 |
| MNDR | hsa-miR-96-5p | Breast cancer luminal | MNDR-E-MI-72653 |
| MNDR | hsa-miR-96-5p | Hearing loss central | MNDR-E-MI-72654 |
| MNDR | hsa-miR-96-5p | Sensorineural hearing loss | MNDR-E-MI-72655 |
| MNDR | hsa-miR-96-5p | Small intestine cancer | MNDR-E-MI-72656 |
| MNDR | hsa-miR-96-5p | Dermatomyositis | MNDR-E-MI-72657 |
| MNDR | hsa-miR-96-5p | Prostate cancer | MNDR-E-MI-72658 |
| MNDR | hsa-miR-96-5p | Gastric cancer | MNDR-E-MI-72659 |
| MNDR | hsa-miR-96-5p | Gastric lymphoma | MNDR-E-MI-72660 |
| MNDR | hsa-miR-96-5p | Retinitis pigmentosa | MNDR-E-MI-72661 |
| MNDR | hsa-miR-96-5p | Alzheimer disease | MNDR-E-MI-72662 |
| MNDR | hsa-miR-96-5p | Intracranial aneurysm | MNDR-E-MI-72663 |
| MNDR | hsa-miR-96-5p | Bladder cancer | MNDR-E-MI-72664 |
| MNDR | hsa-miR-96-5p | Leukemia | MNDR-E-MI-72665 |
| MNDR | hsa-miR-96-5p | Ataxia telangiectasia | MNDR-E-MI-72666 |
| MNDR | hsa-miR-96-5p | Cardiovascular disease | MNDR-E-MI-72667 |
| MNDR | hsa-miR-96-5p | Lung cancer | MNDR-E-MI-72668 |
| MNDR | hsa-miR-96-5p | Endometrial cancer | MNDR-E-MI-72669 |
| MNDR | hsa-miR-96-5p | Parkinson disease | MNDR-E-MI-72670 |
| MNDR | hsa-miR-96-5p | Basal-like breast cancer | MNDR-E-MI-72671 |
| MNDR | hsa-miR-96-5p | Neuroendocrine neoplasia | MNDR-E-MI-72672 |
| MNDR | hsa-miR-96-5p | Thyroid cancer | MNDR-E-MI-72673 |
| MNDR | hsa-miR-96-5p | Pituitary neoplasms | MNDR-E-MI-72674 |
| MNDR | hsa-miR-96-5p | Pancreatic cancer | MNDR-E-MI-72675 |
| MNDR | hsa-miR-96-5p | Melanoma | MNDR-E-MI-72676 |
| MNDR | hsa-miR-96-5p | Rectum adenocarcinoma | MNDR-E-MI-72677 |
| MNDR | hsa-miR-96-5p | Nephroblastoma | MNDR-E-MI-72678 |
| MNDR | hsa-miR-96-5p | Colon cancer | MNDR-E-MI-72679 |
| MNDR | hsa-miR-96-5p | Colon adenocarcinoma | MNDR-E-MI-72680 |
| MNDR | hsa-miR-96-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-72681 |
| MNDR | hsa-miR-96-5p | Familial ovarian cancer | MNDR-E-MI-72682 |
| MNDR | hsa-miR-96-5p | Acromegaly | MNDR-E-MI-72683 |
| MNDR | hsa-miR-96-5p | Hereditary spastic paraplegia | MNDR-E-MI-72684 |
| MNDR | hsa-miR-96-5p | Prostate adenocarcinoma | MNDR-E-MI-72685 |
| MNDR | hsa-miR-96-5p | Carcinoma ductal breast | MNDR-E-MI-72686 |
| MNDR | hsa-miR-96-5p | Glioblastoma | MNDR-E-MI-72687 |
| MNDR | hsa-miR-96-5p | Glioma | MNDR-E-MI-72688 |
| MNDR | hsa-miR-96-5p | Osteosarcoma | MNDR-E-MI-72689 |
| MNDR | hsa-miR-96-5p | Liposarcoma | MNDR-E-MI-72690 |
| MNDR | hsa-miR-96-5p | Breast carcinoma | MNDR-E-MI-72691 |
| MNDR | hsa-miR-96-5p | Meningioma | MNDR-E-MI-72692 |
| MNDR | hsa-miR-96-5p | Liver cancer | MNDR-E-MI-72693 |
| MNDR | hsa-miR-96-5p | Uterine cancer | MNDR-E-MI-72694 |
| MNDR | hsa-miR-96-5p | Gastric adenocarcinoma | MNDR-E-MI-72695 |
| MNDR | hsa-miR-96-5p | Cervical squamous cell carcinoma | MNDR-E-MI-72696 |
| MNDR | hsa-miR-96-5p | Pituitary adenoma | MNDR-E-MI-72697 |
| MNDR | hsa-miR-96-5p | Lung squamous cell carcinoma | MNDR-E-MI-72698 |
| MNDR | hsa-miR-96-5p | Carcinoma lung non-small-cell | MNDR-E-MI-72699 |
| MNDR | hsa-miR-96-5p | Lung adenocarcinoma | MNDR-E-MI-72700 |
| MNDR | hsa-miR-96-5p | Thyroid carcinoma | MNDR-E-MI-72701 |
| MNDR | hsa-miR-96-5p | Bladder urothelial carcinoma | MNDR-E-MI-72702 |
| MNDR | hsa-miR-96-5p | Carcinoma renal cell | MNDR-E-MI-72703 |
| MNDR | hsa-miR-96-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-72704 |
| MNDR | hsa-miR-96-5p | Renal clear cell carcinoma | MNDR-E-MI-72705 |
| MNDR | hsa-miR-96-5p | Large cell carcinoma | MNDR-E-MI-72706 |
| MNDR | hsa-miR-96-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-72707 |
| MNDR | hsa-miR-96-5p | Cholangiocarcinoma | MNDR-E-MI-72708 |
| MNDR | hsa-miR-96-5p | Esophageal cancer | MNDR-E-MI-72709 |
| MNDR | hsa-miR-96-5p | Lung small cell carcinoma | MNDR-E-MI-72710 |
| MNDR | hsa-miR-96-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-72711 |
| MNDR | hsa-miR-96-5p | Testicular germ cell cancer | MNDR-E-MI-72712 |
| MNDR | hsa-miR-96-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-72713 |
| MNDR | hsa-miR-96-5p | Pulmonary arterial hypertension | MNDR-E-MI-72714 |
| MNDR | hsa-miR-96-5p | Breast invasive carcinoma | MNDR-E-MI-72715 |
| MNDR | hsa-miR-96-5p | Hepatocellular carcinoma | MNDR-E-MI-72716 |
| MNDR | hsa-miR-96-5p | Familiar ovarian carcinoma | MNDR-E-MI-72717 |
| MNDR | hsa-miR-96-5p | B-cell lymphoma | MNDR-E-MI-72718 |
| MNDR | hsa-miR-96-5p | Rheumatoid arthritis | MNDR-E-MI-72719 |
| MNDR | hsa-miR-96-5p | T-cell leukemia | MNDR-E-MI-72720 |
| MNDR | hsa-miR-96-5p | Hodgkin lymphoma | MNDR-E-MI-72721 |
| MNDR | hsa-miR-96-5p | Burkitt lymphoma | MNDR-E-MI-72722 |
| MNDR | hsa-miR-96-5p | Tonsil cancer | MNDR-E-MI-72723 |
| MNDR | hsa-miR-96-5p | Acute myelogenous leukemia | MNDR-E-MI-72724 |
| MNDR | hsa-miR-96-5p | Colorectal cancer | MNDR-E-MI-72725 |
| MNDR | hsa-miR-96-5p | Multiple myeloma | MNDR-E-MI-72726 |
| MNDR | hsa-miR-96-5p | Ependymoma | MNDR-E-MI-72727 |
| MNDR | hsa-miR-96-5p | Nasopharyngeal cancer | MNDR-E-MI-72728 |
| MNDR | hsa-miR-96-5p | Prostatic neoplasms | MNDR-E-MI-72729 |
| MNDR | hsa-miR-96-5p | Pancreatitis chronic | MNDR-E-MI-72730 |
| MNDR | hsa-miR-96-5p | Stroke lacunar | MNDR-E-MI-72731 |
| MNDR | hsa-miR-96-5p | Breast cancer her3+ negative | MNDR-E-MI-72732 |
| MNDR | hsa-miR-96-5p | Duke A | MNDR-E-MI-72733 |
| MNDR | hsa-miR-96-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-72734 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADCY6 | Homo sapiens | RR00044518 |
TOP